ahlam1399
07-23-2015, 06:25 PM
Valeant profit beats estimates as U.S. sales stay strong
(Reuters) - Drugmaker Valeant Pharmaceuticals International Inc reported a better-than-expected quarterly profit, helped by strength in its dermatology business in the United States.
http://rc.feedsportal.com/r/234565998247/u/49/f/654207/c/35217/s/485f934d/sc/21/rc/1/rc.img (http://rc.feedsportal.com/r/234565998247/u/49/f/654207/c/35217/s/485f934d/sc/21/rc/1/rc.htm)
http://rc.feedsportal.com/r/234565998247/u/49/f/654207/c/35217/s/485f934d/sc/21/rc/2/rc.img (http://rc.feedsportal.com/r/234565998247/u/49/f/654207/c/35217/s/485f934d/sc/21/rc/2/rc.htm)
http://rc.feedsportal.com/r/234565998247/u/49/f/654207/c/35217/s/485f934d/sc/21/rc/3/rc.img (http://rc.feedsportal.com/r/234565998247/u/49/f/654207/c/35217/s/485f934d/sc/21/rc/3/rc.htm)
http://da.feedsportal.com/r/234565998247/u/49/f/654207/c/35217/s/485f934d/sc/21/a2.img (http://da.feedsportal.com/r/234565998247/u/49/f/654207/c/35217/s/485f934d/sc/21/a2.htm)
http://adchoice.feedsportal.com/r/234565998247/u/49/f/654207/c/35217/s/485f934d/sc/21/ach.img (http://adchoice.feedsportal.com/r/234565998247/u/49/f/654207/c/35217/s/485f934d/sc/21/ach.htm)http://pi.feedsportal.com/r/234565998247/u/49/f/654207/c/35217/s/485f934d/sc/21/a2t.imghttp://pi2.feedsportal.com/r/234565998247/u/49/f/654207/c/35217/s/485f934d/sc/21/a2t2.imghttp://i2.wp.com/reuters.us.feedsportal.com/c/35217/f/654207/s/485f934d/sc/21/mf.gif?resize=1%2C1http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/healthNews?a=NK_LeuO6sXA:ovfc_0ST8VA:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/healthNews?i=NK_LeuO6sXA:ovfc_0ST8VA:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/healthNews?a=NK_LeuO6sXA:ovfc_0ST8VA:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/healthNews?i=NK_LeuO6sXA:ovfc_0ST8VA:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/healthNews?a=NK_LeuO6sXA:ovfc_0ST8VA:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/healthNews/~4/NK_LeuO6sXA
(Reuters) - Drugmaker Valeant Pharmaceuticals International Inc reported a better-than-expected quarterly profit, helped by strength in its dermatology business in the United States.
http://rc.feedsportal.com/r/234565998247/u/49/f/654207/c/35217/s/485f934d/sc/21/rc/1/rc.img (http://rc.feedsportal.com/r/234565998247/u/49/f/654207/c/35217/s/485f934d/sc/21/rc/1/rc.htm)
http://rc.feedsportal.com/r/234565998247/u/49/f/654207/c/35217/s/485f934d/sc/21/rc/2/rc.img (http://rc.feedsportal.com/r/234565998247/u/49/f/654207/c/35217/s/485f934d/sc/21/rc/2/rc.htm)
http://rc.feedsportal.com/r/234565998247/u/49/f/654207/c/35217/s/485f934d/sc/21/rc/3/rc.img (http://rc.feedsportal.com/r/234565998247/u/49/f/654207/c/35217/s/485f934d/sc/21/rc/3/rc.htm)
http://da.feedsportal.com/r/234565998247/u/49/f/654207/c/35217/s/485f934d/sc/21/a2.img (http://da.feedsportal.com/r/234565998247/u/49/f/654207/c/35217/s/485f934d/sc/21/a2.htm)
http://adchoice.feedsportal.com/r/234565998247/u/49/f/654207/c/35217/s/485f934d/sc/21/ach.img (http://adchoice.feedsportal.com/r/234565998247/u/49/f/654207/c/35217/s/485f934d/sc/21/ach.htm)http://pi.feedsportal.com/r/234565998247/u/49/f/654207/c/35217/s/485f934d/sc/21/a2t.imghttp://pi2.feedsportal.com/r/234565998247/u/49/f/654207/c/35217/s/485f934d/sc/21/a2t2.imghttp://i2.wp.com/reuters.us.feedsportal.com/c/35217/f/654207/s/485f934d/sc/21/mf.gif?resize=1%2C1http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/healthNews?a=NK_LeuO6sXA:ovfc_0ST8VA:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/healthNews?i=NK_LeuO6sXA:ovfc_0ST8VA:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/healthNews?a=NK_LeuO6sXA:ovfc_0ST8VA:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/healthNews?i=NK_LeuO6sXA:ovfc_0ST8VA:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/healthNews?a=NK_LeuO6sXA:ovfc_0ST8VA:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/healthNews/~4/NK_LeuO6sXA